Log In
BCIQ
Print this Print this
 

RG7876

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionCD40 imAb and PD-L1 mAb
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today